APA (7th ed.) Citation

CC, S., AE, H., KE, R., K, K., GG, H., M, M., . . . SB, K. (2024). Axillary management and long-term oncologic outcomes in breast cancer patients with clinical N1 disease treated with neoadjuvant chemotherapy. World journal of surgical oncology, 22(1), 199. https://doi.org/10.1186/s12957-024-03477-4

Chicago Style (17th ed.) Citation

CC, Sparger, et al. "Axillary Management and Long-term Oncologic Outcomes in Breast Cancer Patients with Clinical N1 Disease Treated with Neoadjuvant Chemotherapy." World Journal of Surgical Oncology 22, no. 1 (2024): 199. https://doi.org/10.1186/s12957-024-03477-4.

MLA (9th ed.) Citation

CC, Sparger, et al. "Axillary Management and Long-term Oncologic Outcomes in Breast Cancer Patients with Clinical N1 Disease Treated with Neoadjuvant Chemotherapy." World Journal of Surgical Oncology, vol. 22, no. 1, 2024, p. 199, https://doi.org/10.1186/s12957-024-03477-4.